Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Kappes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Immunology|August 24, 2023
Doubling down to make killer T cellsDietmar Kappes, David L Wiest
Blood|October 5, 2012
The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cellsIsaac Engel, Meng Zhao, Dietmar Kappes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2011
TOX is required for development of the CD4 T cell lineage gene programParinaz Aliahmad, Asha Kadavallore, Brian de la Torre, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 2, 2018
Novel mutation in Teneurin 3 found to co-segregate in all affecteds in a multi-generation family with developmental dysplasia of the hipGeorge Feldman, Dietmar Kappes, Jayati Mookerjee-Basu, et al.
Immunity|March 20, 2012
E protein transcription factors are required for the development of CD4(+) lineage T cellsMary Elizabeth Jones-Mason, Xudong Zhao, Dietmar Kappes, et al.
The Journal of Experimental Medicine|April 21, 2010
Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selectionIsaac Engel, Kirsten Hammond, Barbara A Sullivan, et al.
Oncogene|December 3, 2022
Interferon-gamma signaling promotes melanoma progression and metastasisBo Zhou, Jayati Basu, Hasan Raza Kazmi, et al.
Blood|April 18, 2022
The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasmYong Zhang, Billy Truong, Shawn P Fahl, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 <sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Research Square|April 16, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeDenise Paula Muñoz, Camila D Arcuschin, Kamin Kahrizi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Immunology|August 24, 2023
Doubling down to make killer T cellsDietmar Kappes, David L Wiest
Blood|October 5, 2012
The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cellsIsaac Engel, Meng Zhao, Dietmar Kappes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2011
TOX is required for development of the CD4 T cell lineage gene programParinaz Aliahmad, Asha Kadavallore, Brian de la Torre, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 2, 2018
Novel mutation in Teneurin 3 found to co-segregate in all affecteds in a multi-generation family with developmental dysplasia of the hipGeorge Feldman, Dietmar Kappes, Jayati Mookerjee-Basu, et al.
Immunity|March 20, 2012
E protein transcription factors are required for the development of CD4(+) lineage T cellsMary Elizabeth Jones-Mason, Xudong Zhao, Dietmar Kappes, et al.
The Journal of Experimental Medicine|April 21, 2010
Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selectionIsaac Engel, Kirsten Hammond, Barbara A Sullivan, et al.
Oncogene|December 3, 2022
Interferon-gamma signaling promotes melanoma progression and metastasisBo Zhou, Jayati Basu, Hasan Raza Kazmi, et al.
Blood|April 18, 2022
The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasmYong Zhang, Billy Truong, Shawn P Fahl, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 <sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Research Square|April 16, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeDenise Paula Muñoz, Camila D Arcuschin, Kamin Kahrizi, et al.
Pageof 2